Form 4: Clorox VP Defers Stock Grant, Reports Ownership Changes

Clorox VP Laurene Peck reported the settlement and deferral of a 2022 performance unit grant, along with tax-related share disposals and updated beneficial ownership.

Summary

• Laurene E. Peck, VP CAO & Corporate Controller of The Clorox Company, reported transactions involving common stock.
• On October 3, 2025, 1,418 shares of common stock were acquired at a price of $122.25 per share, stemming from the settlement of a 2022 Performance Unit Grant that vested on the same date. The reporting person elected to defer this grant pursuant to the 2005 Stock Incentive Plan.
• Concurrently, 36 shares of common stock were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of performance stock units.
• An additional 243 shares of common stock were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock.
• Following these transactions, Laurene E. Peck directly beneficially owns 6,992 shares of common stock.
• The direct beneficial ownership includes 186 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.
• Additionally, 100 shares are indirectly beneficially owned through a Trust of Parent.

Sentiment

Score: 6

Explanation: The filing reflects routine executive compensation activities, including vesting, deferral, and tax-related share disposals. The deferral of the grant could be seen as a positive signal of long-term confidence, but overall it's a neutral, expected event.

Positives

• The reporting person elected to defer the settlement of a 2022 Performance Unit Grant, indicating a long-term commitment or confidence in the company's future performance.
• Beneficial ownership includes 186 shares acquired via a dividend reinvestment feature, demonstrating continued investment through company programs.

Future Outlook

The election to defer the settlement of the 2022 Performance Unit Grant suggests a forward-looking decision by the executive, potentially indicating a belief in the company's sustained performance or a personal long-term investment strategy.

Industry Context

This Form 4 filing details routine insider transactions related to executive compensation and stock ownership, which are common across publicly traded companies. It does not provide broader industry trends or competitive insights.

Stakeholder Impact

• Shareholders: Provides transparency into executive stock ownership and compensation practices, which are routine and expected.
• Employees: Reflects standard equity compensation mechanisms for executives.

Key Dates

Keywords

Clorox, CLX, Form 4, Insider Transaction, Stock Ownership, Executive Compensation, Performance Units, Restricted Stock, Dividend Reinvestment